Form 8-K - Current report:
SEC Accession No. 0001493152-23-030386
Filing Date
2023-08-28
Accepted
2023-08-28 17:13:30
Documents
32
Period of Report
2023-08-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37574
2 ex99-1.htm EX-99.1 15258
3 ex99-1_001.jpg GRAPHIC 439021
4 ex99-1_002.jpg GRAPHIC 385698
5 ex99-1_003.jpg GRAPHIC 499119
6 ex99-1_004.jpg GRAPHIC 334130
7 ex99-1_005.jpg GRAPHIC 350698
8 ex99-1_006.jpg GRAPHIC 377093
9 ex99-1_007.jpg GRAPHIC 398131
10 ex99-1_008.jpg GRAPHIC 241414
11 ex99-1_009.jpg GRAPHIC 340532
12 ex99-1_010.jpg GRAPHIC 354751
13 ex99-1_011.jpg GRAPHIC 388149
14 ex99-1_012.jpg GRAPHIC 322437
15 ex99-1_013.jpg GRAPHIC 335414
16 ex99-1_014.jpg GRAPHIC 394022
17 ex99-1_015.jpg GRAPHIC 359276
18 ex99-1_016.jpg GRAPHIC 308638
19 ex99-1_017.jpg GRAPHIC 298418
20 ex99-1_018.jpg GRAPHIC 432768
21 ex99-1_019.jpg GRAPHIC 360015
  Complete submission text file 0001493152-23-030386.txt   9761189

Data Files

Seq Description Document Type Size
22 XBRL SCHEMA FILE envb-20230828.xsd EX-101.SCH 3012
23 XBRL LABEL FILE envb-20230828_lab.xml EX-101.LAB 34240
24 XBRL PRESENTATION FILE envb-20230828_pre.xml EX-101.PRE 22357
26 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3443
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 231217104
SIC: 2834 Pharmaceutical Preparations